Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal of Cutaneous Medicine and Surgery
|
June 3, 2005
Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials
Stephen K Tyring, Francisco Diaz-Mitoma, Stephen D Shafran, et al.
American Journal of Obstetrics and Gynecology
|
March 14, 2003
A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery
D Heather Watts, Zane A Brown, Deborah Money, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
January 21, 2010
Inadequacy of plasma acyclovir levels at delivery in patients with genital herpes receiving oral acyclovir suppressive therapy in late pregnancy
Daniel T Leung, Paul A Henning, Emily C Wagner, et al.
Antiviral Research
|
October 23, 2004
The synergistic effects of betulin with acyclovir against herpes simplex viruses
Yunhao Gong, Karim M Raj, Carolyn A Luscombe, et al.
Antimicrobial Agents and Chemotherapy
|
April 9, 2014
Three phase III randomized controlled trials of topical resiquimod 0.01-percent gel to reduce anogenital herpes recurrences
Karen E Mark, Spotswood Spruance, George R Kinghorn, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
October 12, 2001
Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility
Robert T Sarisky, Paul Crosson, Rachel Cano, et al.
The Journal of Infectious Diseases
|
April 3, 2007
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial
Karen E Mark, Lawrence Corey, Tze-Chiang Meng, et al.
Hepatology (Baltimore, Md.)
|
July 9, 2004
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B
Patrick Marcellin, Herve Mommeja-Marin, Stephen L Sacks, et al.
The New England Journal of Medicine
|
January 2, 2004
Once-daily valacyclovir to reduce the risk of transmission of genital herpes
Lawrence Corey, Anna Wald, Raj Patel, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal of Cutaneous Medicine and Surgery
|
June 3, 2005
Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials
Stephen K Tyring, Francisco Diaz-Mitoma, Stephen D Shafran, et al.
American Journal of Obstetrics and Gynecology
|
March 14, 2003
A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery
D Heather Watts, Zane A Brown, Deborah Money, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
January 21, 2010
Inadequacy of plasma acyclovir levels at delivery in patients with genital herpes receiving oral acyclovir suppressive therapy in late pregnancy
Daniel T Leung, Paul A Henning, Emily C Wagner, et al.
Antiviral Research
|
October 23, 2004
The synergistic effects of betulin with acyclovir against herpes simplex viruses
Yunhao Gong, Karim M Raj, Carolyn A Luscombe, et al.
Antimicrobial Agents and Chemotherapy
|
April 9, 2014
Three phase III randomized controlled trials of topical resiquimod 0.01-percent gel to reduce anogenital herpes recurrences
Karen E Mark, Spotswood Spruance, George R Kinghorn, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
October 12, 2001
Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility
Robert T Sarisky, Paul Crosson, Rachel Cano, et al.
The Journal of Infectious Diseases
|
April 3, 2007
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial
Karen E Mark, Lawrence Corey, Tze-Chiang Meng, et al.
Hepatology (Baltimore, Md.)
|
July 9, 2004
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B
Patrick Marcellin, Herve Mommeja-Marin, Stephen L Sacks, et al.
The New England Journal of Medicine
|
January 2, 2004
Once-daily valacyclovir to reduce the risk of transmission of genital herpes
Lawrence Corey, Anna Wald, Raj Patel, et al.
Page
of 2